Keyword: ADC

News

Merck Invests $70 Million to Expand ADC Production for Cancer Therapies

30.10.2024 -

Merck KGaA has announced a €70 million expansion of its ADC manufacturing capacity at its Centre of Excellence for Bioconjugation in St. Louis, Missouri, USA. The...

Research / Laboratory

Improving ADC Production and Purification

Lonza AG -

How Optimizing Process Parameters Can Improve Scalability and Manufacturability of a Cytotoxic Antibody Drug Conjugate.

News

Lotte Outlines Plans to Become Major CDMO Player

13.02.2023 -

Lotte Biologics, part of South Korean conglomerate Lotte, has detailed expansions plans for the business as it embarks on a path to become a top 10 CDMO by 2030.

News

Merck Germany Doubles HPAPI Potential

24.06.2022 -

The Life Science business segment of German pharmaceuticals, chemicals and life sciences group Merck has widened its US plant for high-potent active pharmaceutical...

Chemistry & Life Sciences

The Rise of HPAPI Molecules

10.09.2020 -

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

News

ADC Bio to Invest $11m on Bioconjugation Facility

26.09.2017 - ADC Biotechnology (ADC Bio) has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK. A substantial part of...

Research & Innovation

The Winning Formula

06.12.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...

Strategy & Management

The Winning Formula

08.09.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...